Cemvita, an industrial biotech startup, uses waste streams and CO2 to produce carbon-negative materials such as proteins, plastics, and fuel feedstocks by using its synthetic biology platform of engineered microbes. The company's focus is on creating sustainable processes for extracting natural resources, biomanufacturing of carbon-negative chemicals and fuels, and closing the loop by using waste as a feedstock.
Cemvita's key offerings revolve around three main verticals: 1) biomining for lithium and copper extraction, 2) subsurface biochemical production (including gold hydrogen), and 3) biomanufacturing of waste CO2 into valuable products such as sustainable aviation fuel (SAF) and renewable natural gas.
Cemvita also focuses on low-carbon biomanufacturing of chemicals and fuels like bioethylene, sustainable aviation fuel (SAF), and renewable natural gas. The company collaborates with United Airlines Ventures and Oxy Low Carbon Ventures to commercialize the production of SAF using CO2 and synthetic microbes. In April 2023, the company unveiled its eCO2 pilot plant to develop bio-ethylene for use in renewable feedstocks and fertilizers.
Key customers and partnerships
Cemvita collaborated with United Airlines Ventures and Oxy Low Carbon Ventures to commercialize the production of SAF. In 2023, United Airlines agreed to purchase up to 1 billion gallons of SAF from Cemvita over 20 years.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.